Atlas Trials

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Clinical trial NCT00639769 · COMPLETED

Trial details

NCT number
NCT00639769
Sponsor
Vanderbilt-Ingram Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2002-02-01
Primary completion
2007-05-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.